David S. Lee, MD

The Combination of Enoxaparin, Glycoprotein IIb/IIIa Inhibitors and an Early Invasive Approach Among Acute Coronary Syndrome Pat

08/01/2008

Stephen G. Ellis , MD;

Deepak L. Bhatt , MD, MPH, FACC, FAHA, FESC, MSCAI;

David J. Moliterno , MD;

David S. Lee , MD;

Eric J. Topol , MD;

W. Frank Peacock , MD;

ABSTRACT: Objectives. This study was designed to assess the feasibility and safety of enoxaparin in combination with glycoprotein (GP) IIb/IIIa inhibitors during percutaneous coronary intervention (PCI) as part of an early invasive strategy...

ABSTRACT: Objectives. This study...

08/01/2008

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

David S. Lee, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products